Press Releases

CareDx Collaborates with ExamOne, a Quest Diagnostics Company, to Expand Mobile Phlebotomy Coverage Across the United States for Transplant Patients who are High Risk for COVID-19 SOUTH SAN FRANCISCO, Calif. , April 09, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision

SOUTH SAN FRANCISCO, Calif. , April 08, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high value healthcare solutions for transplant patients and caregivers, today

CareDx works with International Consortium of Transplant Leaders on a Global Registry of Transplant Patients Diagnosed with COVID-19 SOUTH SAN FRANCISCO, Calif. , April 06, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,

CareDx Congratulates Johns Hopkins on Successful Follow-Up Using AlloSure of First Retransplant Patient After Immunotherapy SOUTH SAN FRANCISCO, Calif. , March 19, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and

CareDx brings remote solutions to the immunosuppressed transplant community to address COVID-19 concerns SOUTH SAN FRANCISCO, Calif. , March 17, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of

CareDx CMO to Chair Upcoming NKF San Francisco Kidney Walk SOUTH SAN FRANCISCO, Calif. , March 12, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leader in precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high value

CareDx Brings a Leading Presence to the Cutting Edge of Transplantation Meeting with a New AJT Publication and KIRA Study Announcement SOUTH SAN FRANCISCO, Calif. , March 05, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leader in molecular diagnostics focused on the discovery,

SOUTH SAN FRANCISCO, Calif. , Feb. 28, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today

SOUTH SAN FRANCISCO, Calif. , Feb. 27, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high value healthcare solutions for transplant patients and caregivers, today

CareDx Publishes Data in American Journal of Transplantation that can Change the Paradigm of Care for Transplant Patients SOUTH SAN FRANCISCO, Calif. , Feb. 26, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and